Live
- PM Modi highlights govt's efforts to make Odisha prosperous and one of the fastest-growing states
- Hezbollah fires 200 rockets at northern, central Israel, injuring eight
- Allu Arjun's Family Appearance on Unstoppable with NBK Breaks Viewership Records
- Unity of hearts & minds essential for peace & progress, says J&K Lt Governor
- IPL 2025 Auction: I deserve Rs 18 cr price, says Chahal on being acquired by Punjab Kings
- EAM Jaishankar inaugurates new premises of Indian embassy in Rome
- Sailing vessel INSV Tarini embarks on second leg of expedition to New Zealand
- Over 15,000 people affected by rain-related disasters in Sri Lanka
- IPL 2025 Auction: RCB acquire Hazlewood for Rs 12.50 cr; Gujarat Titans bag Prasidh Krishna at Rs 9.5 crore
- Maharashtra result reflects the outcome of Congress' destructive politics: BJP's Shazia Ilmi
PL First Cut – Bayer Cropscience 1QFY24
Prabhudas Lilladher Pvt Ltd
Bayer Cropscience 1QFY24 Result First Cut-Decent performance; in line with estimates
Bayer Cropscience 1QFY24 Result First Cut-Decent performance; in line with estimates
(CMP-Rs4,582; Mcap- Rs206bn; ACCUMULATE; TP-Rs4,720)
❇️ Key highlights of 1QFY24 results:
Revenue: Rs17.4bn, +4% YoY as against our/Cons estimates of Rs17.6bn/Rs17.0bn
Gross Margins: at 42.7% down 580bps YoY
EBITDA: Rs4.2bn, +8% YoY as against our/Cons estimates of Rs4.0bn/Rs4.0bn
EBITDA margin: 24.4%, +70bps YoY as against our and Cons estimates of 22.8%/23.6%
Net Profit: Rs3.3bn, +9% YoY as against our/Cons estimates of Rs3.1bn/Rs3.0bn
❇️ Comments: BYRCS reported decent set of numbers during 1QFY24. Revenue growth (up 4% YoY) (adjusted for effect of customer incentive programs growth was 9% YoY) were largely driven by strong CP sales (despite expected moderation in Round-up (Glyphosate) sales due to lower realisations) and volume growth in corn hybrid seeds. We believe strong growth witnessed in corn hybrid seeds was largely led by better maize acreages in ongoing kharif season (up 0.4% YoY) supported by remunerative corn prices (up 7% YoY to Rs2,295/quintal as on July’23). High cost inventory provisions in CP segment likely to have dent the gross margins (down 580bps YoY) to 42.7%. However, lower employee cost coupled with lower opex down 220bps and 430bps YoY has resulted into EBITDA margin expansion of 70bps YoY to 24.4% (Ple 22.8%). We currently have Accumulate rating on the stock with TP of Rs4,720 based on 25xMarch25 EPS.
